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Improved blood glucose level associated with polypeptide-K (Diabegard®), a 
polypeptide isolated from the seeds of Momordica charantia supplementation: 
evaluation of 6 cases 
 
ABSTRACT 
To describe six cases of glucose management in diabetic and pre-diabetic patients with 
Diabegard® supplementation. We report the clinical courses of six individuals taking 
Diabegard® supplementation at 60 and 120 mg/day for 8 weeks. Patients had a maximum of 
50% reduction in fasting blood glucose with 42% reduction in glycated haemoglobin 
(HbA1c). Patients also had improved kidney functions (expressed by normal level of blood 
urea nitrogen, creatinine and urine microalbumin). In some patients, these three parameters 
were elevated prior to supplementation. These results suggest that supplementation of 
Diabegard® will improve patients' glucose management and with reduction of elevated blood 
glucose level, kidney functions will also improve. However, patients taking this 
supplementation are advised to seek medical consultation in monitoring their blood sugar 
levels.  
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